CLINICAL_TRIALS
trial_result
· 2026-04-14
Clinical Trial Update: Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma [Phase 2]
Summary
Phase 2 trial results assessing fluoxetine to mitigate mental health symptoms in patients with musculoskeletal injuries have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Florida | Conditions: Musculoskeletal Injury | Phase 2 | Status: COMPLETED | Results posted: 2026-04-14